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Metazoan  parasites  typically  induce  a type  2 immune  response,  characterized  by T helper  2  (Th2)  cells  that
produce the  cytokines  IL-4, IL-5  and  IL-13  among  others.  The type  2  response  is host  protective,  reducing
the  number  of  parasites  either  through  direct  killing  in the  tissues,  or expulsion  from  the  intestine.  Type
2  immunity  also  protects  the host  against  damage  mediated  by  these  large  extracellular  parasites  as
they  migrate  through  the  body.  At  the  center  of both  the  innate  and adaptive  type  2  immune  response,
is  the IL-4R  that  mediates  many  of the  key effector  functions.  Here  we highlight  the striking  overlap
between the molecules,  cells  and  pathways  that  mediate  both  parasite  control  and  tissue  repair.  We
have  proposed  that  adaptive  Th2  immunity  evolved  out of  our  innate  repair  pathways  to  mediate  both
accelerated  repair  and  parasite  control  in  the  face  of continual  assault  from  multicellular  pathogens.  Type
2 cytokines  are  involved  in many  aspects  of  mammalian  physiology  independent  of helminth  infection.
Therefore  understanding  the evolutionary  relationship  between  helminth  killing  and  tissue  repair  should
provide new  insight  into  immune  mechanisms  of  tissue  protection  in  the  face  of physical  injury.
© 2014  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license
(http://creativecommons.org/licenses/by/3.0/).. Introduction
Multicellular metazoan parasites of mammals, also known as
elminths, typically induce a Th2-type (type 2) immune response
n the infected host. Type 2 immunity is a highly complex multi-
ellular, multifactorial system characterized by the cytokines IL-4,
, 9, 10 and 13 [1]. These cytokines are produced by Th2 lym-
hocytes, but also by a range of innate immune cells including
asophils, eosinophils, mast cells and innate lymphoid cells (ILCs).
he IL-4R alpha chain (IL-4R),  a component of both the IL-4 and
L-13 receptor, is fundamental to type 2 immune function [1], with
xpression and engagement of IL-4R on immune effector cells
e.g. macrophages, B cells) and tissue cells (e.g. smooth muscle,
pithelial cells) dictating the outcome of a type 2 immune response.
etails of type 2 immunity are constantly emerging, including the
iscovery of new cells, such as ILCs, which are central to type 2
mmune function. These processes, particularly as they apply to
elminth immunity have been reviewed recently [1–3].
Abbreviations: IL-4R, Interleukin-4 receptor alpha; ILC, innate lymphoid cell;
SLP, thymic stromal lymphopoietin; AAM, alternatively activated macrophage.
∗ Corresponding author at: School of Biological Sciences, West Mains Road, Edin-
urgh EH9 3JT, United Kingdom. Tel.: +44 0 131 650 7014.
E-mail address: j.allen@ed.ac.uk (J.E. Allen).
ttp://dx.doi.org/10.1016/j.smim.2014.06.003
044-5323/© 2014 The Authors. Published by Elsevier Ltd. This is an open access article uThe triggers that initiate a type 2 immune response have been
under intense investigation for many years with little consensus
on the essential pathways that lead to a robust response. However,
recently there has been an emerging literature on the critical role
of mucosal barriers. In particular, epithelial cells release alarmins,
IL-25, IL-33 and thymic stromal lymphopoietin (TSLP) [4], all three
of which promote Th2 immunity. It is becoming increasingly appar-
ent that we have a robust cytokine alert system to tissue injury that
will activate a type 2 immune response in the absence of a more
dominant type 1 trigger [5]. Recently, Patel et al. [6] directly linked
cellular damage to the induction of protective immunity against a
gastrointestinal nematode by demonstrating that release of extra-
cellular adenosine was responsible for inducing the Th2 response.
Consistent with this, mast cells, which act as sentinels of injury [7],
and other innate cells such as eosinophils and basophils, can readily
produce IL-4 which has long been implicated in the generation of
a type 2 immune response [8].
Tissue injury alone does not always generate a type 2
response. Additionally, helminth products themselves can induce
Th2 responses in the absence of injury [9,10]. Thus, over evolu-
tionary time it seems that mammals have learned to recognize
the presence of potentially damaging large multicellular orga-
nisms, and initiate a response that largely resembles a reaction
to tissue injury. This association between tissue injury and infec-
tion with metazoan parasites makes sense. Metazoan parasites do
nder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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ot typically replicate in their hosts; instead they enter as lar-
al stages, frequently migrate through tissues to their established
iche, grow through developmental stages to sexual maturity, mate
nd release offspring to infect a new host. Faced with these large
issue migrating invaders, a pro-inﬂammatory type 1 response,
lthough potentially damaging to the parasite, is even more likely
o damage the host. Thus, a response that limited type 1 inﬂam-
ation and facilitated wound healing would be beneﬁcial. Ideally,
his same response, where possible, would contribute to parasite
ontrol, either by limiting their numbers, hindering their devel-
pment, restricting their motility, or preventing new incoming
nfections. Indeed, this does appear to be the case. The overlap
etween injury repair pathways and parasite control is striking,
s this review will illustrate. The relationship between parasite
illing and wound repair is also reﬂected in the association of
brosis with helminth infection [11]. The requirement for rapid tis-
ue repair following parasite migration, can necessitate aggressive
atrix deposition, the natural consequence of which is formation
f scar tissue and ﬁbrosis [12]. IL-13 appears to be the critical type
 cytokine involved in the ﬁbrotic response, both through direct
ffects on collagen production and deposition and indirect effects
n promoting TGF-mediated repair [13]. IL-13 and/or IL-4, which
oth use the IL-4R chain, are also central to resistance against
any if not most helminth infections [1].
Infection with the rodent gastrointestinal nematode, Nip-
ostrongylus brasiliensis has proved a powerful and useful model
o evaluate both control of nematode numbers and repair of dam-
ge caused by nematode migration. Throughout this review, N.
rasiliensis will be used to illustrate the dual function of so many
ore components of the type 2 immune response, although other
odels will be described where relevant. As with the related hook-
orm parasites of man, N. brasiliensis larvae invade by penetrating
he skin and entering the blood vessels where they are swept to
he lung (Fig. 1). Parasites burst from the capillary bed into the lung
arenchyma, causing substantial bleeding. Once in the lung, the lar-
ae undergo one molt and within 48 h move into the airways and
rachea, where they are coughed up and swallowed by the host. In
he gastrointestinal tract parasites reach sexual maturity and pro-
uce eggs. Atypical of many helminth infections, N. brasiliensis in
ice is a relatively acute infection and depending on parasite/host
trains, adult worms are expelled from the gut in 1 to 2 weeks.
xpulsion is highly Th2 dependent, with a critical role for Stat-6
nd the IL-4R [14], responses that are also needed for protection
rom re-infection [15]. Whilst larval migration through the lung
auses considerable damage, the tissue is rapidly repaired in a pro-
ess dependent on type 2 activated macrophages [16]. Nonetheless,
he progressive airway remodeling that occurs can lead to deﬁcits
n lung function and after some 50 days post infection, the lung in
ll strains of infected mice exhibit an emphysematous morphology
f unknown origin [17,18].
. Alerting the immune system to injury
IL-33, IL-25 and TSLP alert the immune system to injury and pro-
ote the development of a type 2 immune response. Each of these
olecules illustrates the intimate relationship between parasite
ontrol and injury repair (Fig. 2).
.1. Interleukin-33
IL-33 is a member of the IL-1 family and its receptor, ST2, is
xpressed on mast cells, Th2 cells [19], ILC2s [20,21] and can be
ighly upregulated on macrophages by Th2 cytokines [22]. In keep-
ng with its designation as an alarmin, IL-33 is released in a bioactive
orm by dying cells [23] and a key mechanism by which mast cellsImmunology 26 (2014) 329–340
respond to injury is via recognition of IL-33 [7]. IL-33 promotes mul-
tiple aspects type 2 immunity [19] and this has been documented in
the context of helminth exposure through intravenous administra-
tion of Schistosoma mansoni eggs, one of the most potent inducers of
type 2 immunity known. Mice that lack ST2 fail to develop primary
Th2 responses or form Th2-dependent lung granulomas around the
eggs [24]. Thus, the evidence that IL-33 acts by alerting the immune
system to injury and induces type 2 immune responses is strong.
The response elicited by IL-33 also impacts on the repair process
and this is documented by accelerated repair of incisional wounds
following IL-33 administration [25] and emerging evidence for IL-
33 in epithelial restoration and mucosal healing in the gut [26].
The promotion of type 2 cytokines and healing, also means IL-33
contributes to ﬁbrosis in a variety of experimental models [27,28].
As a potent initiator of Th2 responses, it was logical to test
the role of IL-33 in Trichuris muris,  a nematode infection that is
strictly dependent on Th2 immunity for parasite expulsion from
the intestine. Humphreys et al. [29] demonstrated that IL-33 mRNA
was elevated early following infection, and that administration of
recombinant IL-33 was  sufﬁcient to accelerate clearance of the
parasite. The importance of IL-33 for parasite control was also
demonstrated for N. brasiliensis,  where IL-33 is needed in both
primary and secondary infection to promote expulsion [30]. The
effect on worm expulsion was  due to the ability of IL-33 to pro-
mote IL-13 production by both ILCs and CD4+ T cells, which in turn
increases production of the anti-worm effector molecule RELM  by
intestinal epithelial cells. In this same study, IL-33 deﬁciency led to
greater hemorrhaging at day 3 post infection, along with reduced
eosinophil recruitment to the lung. Thus IL-33 is critical for worm
expulsion, while also minimizing host damage early in infection
[30].
2.2. Interleukin 25
IL-25 is a member of the IL-17 cytokine family produced by
epithelial cells, amongst other cell types, and is likely a sensor of
epithelial disruption [4]. Like IL-33, IL-25 induces the production of
type 2 cytokines by ILCs. As a direct result, type 2 cytokine responses
and parasite expulsion are delayed in N. brasiliensis infected IL-
25 deﬁcient mice [31]. Further, delivery of recombinant IL-25
into RAG-deﬁcient mice is sufﬁcient to mediate parasite expul-
sion [31,32]. Similarly, when mice normally susceptible to T. muris
infection were treated with IL-25, they were able to effectively
expel the parasite, while IL-25 deﬁciency on the genetically resis-
tant background prevented worm expulsion [33]. Similar methods
revealed that IL-25 protected against infection with Trichinella spi-
ralis, including reducing both the worm burden in the intestine and
the number of larvae in the muscles [34]. Together these studies
demonstrated the potency of IL-25 as an anti-nematode effector.
Importantly, in the T. muris study, Owyang et al. demonstrated that
IL-25 was able to limit the intestinal inﬂammation and tissue dam-
age in the colon associated with this infection demonstrating the
dual roles of this alarmin cytokine [33]. Independently of helminth
infection, the anti-inﬂammatory properties of IL-25 that protect
against gut damage are also reﬂected in studies of type 1 induced
colitis [35,36]. Not surprisingly, because of its ability to enhance
type 2 responses, IL-25 also promotes allergic responses that them-
selves can lead to tissue damage and remodeling [37] as well as
ﬁbrosis [38], the consequence of aggressive wound repair.
2.3. Thymic stromal lymphopoietin (TSLP)TSLP is a member of the IL-2 cytokine family expressed pre-
dominantly by epithelial cells. Expression of TSLP is constitutive
in the lung and gut where it is believed to suppress inﬂamma-
tory type 1 responses and promote type 2 responses [39]. TSLP
J.E. Allen, T.E. Sutherland / Seminars in Immunology 26 (2014) 329–340 331
Fig. 1. Life cycle of N. brasiliensis in mice, demonstrating sites where tissue injury occurs. Stage 3 larvae (L3) infect the host by penetrating the skin resulting in local inﬁltration
of  host neutrophils and esoinophils. L3s enter blood vessels (∼6 h post-infection) and migrate to the lung bursting through capillaries (∼18–72 h) where, in the parenchyma,
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hrough  into the airways, are coughed up, swallowed and enter into the intestine w
ocal  tissue damage and inﬂammation before being expelled in a highly Th2-depen
an be further induced upon tissue injury and is associated with
rotection of mucosal surfaces [39]. However, its expression is not
imited to the barrier surfaces, but TSLP is also induced in response
o damage or injury in other tissues such as the liver [40] and the
entral nervous system [41]. The ability of TSLP to promote Th2
esponses is in part due TSLP receptor expression on dendritic cells
42]. Beyond the promotion of Th2 cells, TSLP ampliﬁes type 2 effec-
or responses, for example by enhancing the polarizing effects of
L-13 on macrophages [43].
An important role for TSLP in resistance to helminth infection
as shown by infection of mice with T. muris, in which TSLP block-
de made resistant mice susceptible and TSLP receptor deﬁcient
ice have enhanced worm burdens [44]. It was somewhat surpris-
ng, therefore, when other models of helminth infection including
. brasiliensis failed to demonstrate a role for TSLP in host protec-
ion [45]. Massacand et al. [45] were able to explain this discrepancy
y demonstrating that the major function of TSLP during T. muris
nfection was to suppress IL-12p40. Because N. brasiliensis and H.
olygyrus parasites directly inhibit host IL-12p40, a feature typ-
cal of many nematode infections, the contribution of TSLP was
edundant. Thus a major mechanism by which TSLP promotes
ype 2 immunity is likely to be through the suppression of type
 responses. Nonetheless, in the appropriate context, this allows
he host to mount an effective anti-helminth response.
Evidence for a role of TSLP in wound repair comes from stud-
es demonstrating reduced ﬁbrosis in the absence of TSLP or its
eceptor. In liver ﬁbrosis induced by deposition of S. mansoni eggs,
brosis was attenuated in TSLP receptor deﬁcient mice and this was
ssociated with decreased IL-13 production [46]. Although ﬁbrosis
s a negative consequence of poorly regulated repair, the functions
f TSLP that have been elucidated in ﬁbrosis models provide direct
vidence for its repair function. For example, in a model of atopic
ermatitis, TSLP directly promotes ﬁbrocytes, cells that circulate
n the peripheral blood and produce connective tissue proteins,ads to hemorrhage and acute lung injury. After approximately 48 h, larvae break
parasites mature and produce eggs (72 h). Adults that reside in the intestine cause
anner.
to produce collagen. Neutralization of TSLP or genetic deletion of
TSLPR resulted in a signiﬁcant reduction in the number of ﬁbrocytes
and in skin ﬁbrosis. Interestingly, this tissue remodeling function
of TSLP was independent of IL-13 and likely due to TSLP receptor
expression on ﬁbrocytes [47].
2.4. Innate lymphoid cells
All three alarmins described above promote Th2 responses in a
large part through their ability to induce IL-5 and IL-13 production
from ILCs [48]. ILCs are distinct groups of innate cells that display
transcriptional and functional attributes directly analogous to the
adaptive T helper effector cells, Th1, Th2, Th17. Speciﬁcally ILC2s,
like Th2 cells, can produce IL-5, IL-9 and IL-13 and require GATA-3
for lineage commitment [reviewed in 49]. Furthermore, ILC2s are
an essential component for the induction of adaptive Th2 cells after
lung allergen exposure, as was  shown recently by the ability of ILC
derived IL-13 to promote migration of CD40+ DCs to the draining
lymph nodes [50]. Early discovery of ILC2s was  in the context of N.
brasiliensis infection [31,51] and ILC2s were subsequently shown
to promote expulsion of the parasite from the gastrointestinal (GI)
tract [20,21,32]. In this infection context, IL-13 producing ILC2s pro-
motes goblet cell mucus secretion and smooth muscle contraction,
processes that mediate the expulsion of helminth parasites.
The N. brasiliensis model has recently been used to elegantly
illustrate the contribution of ILCs to both lung repair and worm
expulsion, while simultaneously revealing a critical role for IL-9 in
both these processes [52]. Turner et al. demonstrate that during
infection, ILC2s are the dominant IL-9 producing cell in the lung. In
mice lacking the IL-9 receptor, the lungs fail to repair appropriately
following larval migration, with prolonged micro-bleeding and
the subsequent emphysema-like damage dramatically increased.
In addition, worm expulsion from the GI tract is delayed in the
absence of the IL-9 receptor on hematopoietic cells. Therefore,
332 J.E. Allen, T.E. Sutherland / Seminars in Immunology 26 (2014) 329–340
Fig. 2. Effector molecules involved in type 2 immune responses and host repair following N. brasiliensis infection. While the pathways involved in immune-mediated
clearance and repair of tissue damage can be applied to infection of most helminths, the effector molecules depicted here apply speciﬁcally to infection with N. brasiliensis.
As  larvae pass through the lung, acute lung injury ensues following danger associated molecular patterns (DAMPs) and IL-1 secretion from airway epithelial cells, which in
turn  triggers IL-17 production and recruitment of neutrophils. Neutrophil inﬂux in combination with mechanical damage from migrating larvae leads to injury and tissue
hemorrhage. Concurrently, alarmins IL-33 and IL-25 are secreted from epithelial cells leading to recruitment and activation of both CD4+ T cells and innate lymphoid cells.
Type  2 cytokines IL-4, 13, 9 and 5 increase in the tissue leading to eosinophilia, which in turn contributes to the pool of IL-4. Macrophages in the lung become alternatively
activated by engagement of the IL-4Ra and secret factors such as RELM,  Ym1, arginase (Arg1) and insulin growth factor (IgF) that inhibit IL-17 production limiting further
tissue  damage. Additionally M2  macrophages simultaneously facilitate repair of the lung, along with eosinophils. Responses that occur in intestine follow a similar trend,
although the damage from infection is not only initiated by parasite migration but also feeding on the intestine wall. Alarmins together with dendritic cells and mast cells
stimulate a type 2 immune response resulting in alternative macrophage activation. AAM not only secrete mediators, like RELM that help toward repair of the tissue and
extracellular matrix remodeling, but are also involved in parasite killing following activation by parasite-speciﬁc antibodies secreted by B cells. Critically, epithelial cells and
goblet  cells play a key role in repair of tissue by generating factors like TGF, RELM and RELM which contribute to extracellular matrix turnover. Approximately 1 week
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ucus  production in the epithelium. It is important to note that while TSLP effector f
actor  in other helminth models as discussed in Section 2.3.
he authors conclude that ILC-derived IL-9 promotes lung repair
nd worm expulsion. In the absence of IL-9 there is signiﬁcantly
educed eosinophils and IL-4R-activated macrophages as mea-
ured by RELM,  presumably because a reduction in ILCs would
ead to insufﬁcient IL-5 and IL-13 production and a failure to induce
 sufﬁcient adaptive Th2 response. ILCs in this setting also produce
mphiregulin that might contribute to repair (discussed below).
. Macrophages
Many of the tissue protective functions of IL-4 or IL-13 produced
y ILCs, Th2 cells or other innate cells are likely to be carried out
y macrophages. Macrophages express receptors for both IL-4 and
L-13 and their receptors share the common IL-4R chain, which is
entral to most type 2 effector responses [1]. For the purposes of this
eview, alternatively activated macrophages (AAM)  are speciﬁ-
ally deﬁned as cells that respond to signaling through the IL-4R,
ollowing the original deﬁnition by Siamon Gordon [53].
.1. Macrophages and helminth killing
There is a new emerging literature on the ability of macrophages
o kill nematodes in a Th2 context [54–56]. Despite evidence
hat the granulomas around dying nematodes are predominantly
acrophages [57] and that macrophages can kill in vitro [reviewed
n 58], it has taken surprisingly long for this data to emerge in
ivo. This may  be due to the difﬁculties in effectively deplet-
ng macrophages or because of redundant mechanisms and theype 2 dependent manner involving IL-13-driven muscle contraction and increased
n is redundant for host-protection against N. brasiliensis infection it is an important
fact that macrophages apparently do not act alone. For example,
Bonne-Anne et al. recently demonstrated that both human and
mouse macrophages collaborate with neutrophils to kill larvae of
the nematode Strongyloides stercoralis [59]. In their studies, com-
plement, neutrophils and macrophages are all involved. Although
either neutrophils or macrophages need to be in contact with the
worm, the cell types can be separated from each other. So sol-
uble communication between the cells is needed but either one
can kill. While in vivo studies showed that naïve macrophages
could kill parasites given enough time, AAM are the most effec-
tive. Therefore, IL-4R activation of macrophages accelerates the
parasite killing process.
A seminal study by Anthony et al. demonstrated that clodronate-
mediated monocyte depletion prevented worm expulsion during
secondary H. polygyrus infection [60] and more recently, antibody
has been shown to play a critical role in activating macrophages
to kill in H. polygyrus infection [55]. Critically, the effects of
macrophages may  not always be direct. For example in N. brasilien-
sis infection, macrophage depletion alters intestinal smooth muscle
function that is involved in worm expulsion [61]. All three of these
studies suggest arginase as an important anti-parasite mediator
(discussed below).
Although depletion studies have strongly implicated
macrophages in killing or expulsion, the speciﬁc contribution
of the IL-4R has been less clear. Results with LysMCre deletion
of the IL-4R have been inconsistent, perhaps due to incom-
plete depletion in these mice and the propensity for the IL-4R
positive cells to outcompete the gene-deleted cells in high IL-4
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nvironments [62]. Furthermore, with the exception of arginase,
he evidence that IL-4 induced proteins contribute to worm attri-
ion is still lacking. Indeed, RELM,  one of the most highly induced
roteins in AAM, may  inhibit worm killing due to it’s ability to
egatively regulate type 2 immunity [63,64].
There is no doubt that the mechanisms by which AAM con-
ribute to worm control will be highly varied, from direct targeting
f the worm, to the regulation of glucose transport in the intes-
ine that alters epithelial cell function [65], and to recruitment of
osinophils [22,66]. The broad phylogenetic diversity of helminth
arasites, their distinct host niches, migratory routes, and mech-
nisms of host manipulation make ﬁnding a common answer
o “How do macrophages kill worms?” very unlikely. Similarly,
o single pathway will be exploited by AAM to repair tissue.
he interesting common ground may  be the intersection between
orm killing and tissue repair, where the same pathways, e.g.
pithelial cell turnover or eosinophil recruitment, lead to different
ut not mutually exclusive outcomes.
.2. Alternatively activated macrophages in repair
There is a large and growing literature documenting that a
eprogramming of macrophages away from an M1  phenotype
romotes tissue repair and regeneration [reviewed in 67]. These
repair’ macrophages are typically called M2,  but this encompasses
n enormous range of potential phenotypes, and the speciﬁc con-
ribution of IL-4R signaling to repair and regeneration processes
till needs to be elucidated. The evidence that IL-4R signaling
n macrophages contributes to repair is mainly circumstantial
lthough increasingly strong. The IL-4R dependent production of
rginase is one of the earliest and best examples, and the contribu-
ion to tissue remodeling and repair is a well established property of
rginase 1, which is discussed below. These properties also explain
he frequent association of arginase with ﬁbrosis and in particu-
ar asthma, where it is believed to contribute to pathological tissue
emodeling [68].
In addition to arginase, Ym1/2 (chi3l3/chi3l4) and RELM  (retlna)
re highly but transiently unregulated in response to incisional
ounding in an IL-4R dependent manner [69]. Although no spe-
iﬁc repair function has been deﬁned for the chitinase-like proteins
ncluding Ym1, they bind extracellular matrix [70] and are fre-
uently identiﬁed in injury settings [69–71]. There is considerably
ore evidence for a pro-repair role for RELM,  which has docu-
ented angiogenic properties [72]. However, the contribution of
ELM to be repair may  be highly complicated by it’s ability to
uppress Th2 responses, so although it apparently has direct repair
unctions, it also acts in a negative feedback loop to control ﬁbrosis
63,64].
Many other repair proteins are regulated by IL-4 or IL-13
n macrophages contributing to the evidence that tissue protec-
ion is a key function for AAM. For example, transcriptionally
e observed that extracellular matrix degrading matrix metallo-
roteases (MMP)  are actively down regulated by the IL-4R in
acrophages, while their inhibitors (TIMP1 and TIMP2) are upre-
ulated [22]. Similarly, we observe IL-4R induction of insulin like
rowth factor (IGF-1) during helminth infection [22] as previously
emonstrated in vitro [73]. IGF-1 has a long established role in
epair in part through its ability to stimulate the proliferation and
urvival of ﬁbroblasts and myoﬁbroblasts and promote matrix pro-
uction. The importance of both IGF-1 and AAM in tissue repair
as illustrated by Chen et al. [16]. In that study, IGF-1 producing
AM were needed to repair the damage caused by lung migrating
. brasiliensis larvae.
A recent study demonstrated that AAM take up collagen
ggressively through the mannose receptor and degrade it, poten-
ially identifying a speciﬁc function for AAM in repair [74].Immunology 26 (2014) 329–340 333
Although more direct evidence is still needed, there is little doubt
that macrophages activated via the IL-4R contribute to repair. The
future challenge will be to identify the speciﬁc functions of AAM-
derived repair molecules in speciﬁc settings and functions. This will
require testing the quality and rate of repair in macrophage speciﬁc
deletions including the IL-4R itself.
3.3. Alternatively activated macrophages in regulating
inﬂammation
Although the speciﬁc roles Th2 induced proteins play in the
complex orchestra of tissue repair and remodeling is still being
established, an important contribution may  be to rapidly shut
down the early inﬂammatory response to injury in order to allow
wound repair to progress [75]. Thus, the well-documented anti-
inﬂammatory nature of AAM is one important feature that is
likely central to their wound repair functions. This makes evo-
lutionary sense in the context of immunity to helminths: a host
infected with macroparasites would want to repair any damage
caused by the pathogen but also avoid the damaging consequences
of mounting an inﬂammatory response to a large tissue migrating
parasite.
The data supporting an anti-inﬂammatory role for AAM
has been largely based on the evidence that AAM are impor-
tant sources of down-regulatory cytokines including TGF-
[76,77], PGE2 [78] and the IL-1 receptor antagonist [77,79]. The
chemokine expression proﬁle is also strongly associated with a
non-inﬂammatory role [80] and with speciﬁc down-regulation
of key pro-inﬂammatory chemokines by IL-4 [22,79,81]. Strong
evidence that AAM have a combined anti-inﬂammatory/wound
healing function comes from a study of S. mansoni infection in mice
that lack the IL-4R speciﬁcally on macrophages and neutrophils
and thus completely lack AAM but have otherwise intact Th2
responses [82]. Following S. mansoni infection, these mice die from
overwhelming inﬂammatory responses in the intestine and leak-
age of bacteria into the blood. The data suggests that in the absence
of AAM,  these mice were unable to repair the damage caused by
egg migration through the intestinal wall.
TGF- nicely illustrates that a single protein can be both
anti-inﬂammatory and a critical mediator of repair, and its dam-
aging sequela, ﬁbrosis [83]. Similarly, the AAM product 12/15
lipoxygenase is needed for effective wound repair [84] but atten-
uates pro-inﬂammatory macrophage activation [85]. Although
IL-10 is very strongly associated with an M2 phenotype, and
is often listed as a prototypic cytokine associated with alterna-
tive activation [54,77], it is not speciﬁcally an IL-4R dependent
macrophage product. RNAseq analysis comparing WT  to IL-4R−/−
macrophages had sufﬁcient depth of coverage to be able to say cat-
egorically that IL-10 is not produced by F4/80 macrophages in the
context of ﬁlarial nematode infection [22]. Similarly, the important
source of IL-10 following both hookworm migration through the
lung and ﬁlarial nematode infection appears to be T cells and not
AAM [16,86]. This is consistent with very recent data in which
the critical anti-inﬂammatory roles of macrophages in the gut are
mediated by their ability to respond to IL-10 rather than the produc-
tion of IL-10 [87]. IL-10 production by macrophages may be more
related to the ability of classical pro-inﬂammatory macrophages to
self-regulate [88].
3.4. Tissue resident vs. recruited macrophages
The recent paradigm shift in our understanding of macrophage
biology [89] adds a new layer of complexity to the contribution of
AAM to infection control and repair. Until very recently, it was
generally understood that most tissue macrophages are derived
from the bone marrow via blood circulating monocytes. We  now
3 ars in Immunology 26 (2014) 329–340
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Box 1: Unanswered Questions
• What is speciﬁc contribution of IL-4R signaling to repair and
regeneration processes?
• What are the speciﬁc properties of IL-4R induced products
such as RELMa, arginase and YM1  that mediate repair and/or
worm killing?
• How do single molecules perform both repair functions and
parasite killing? Does the cellular source matter?
• What are the distinct functions of different cell types such
as macrophages and epithelial cells, when activated via the
IL-4R?
• Are there distinct functions for resident vs. monocyte-
derived macrophages in repair or helminth control?
• What is speciﬁc contribution of eosinophils to repair and
regeneration processes?
• What are the circumstances in which adaptive immunity con-34 J.E. Allen, T.E. Sutherland / Semin
ealize that in fact many tissue-resident macrophages including the
pleen, serous cavities and liver are established in the tissue pre-
atally by embryonic precursors that are sustained by a process of
ontinual self-renewal [reviewed in 89]. Alveolar macrophages are
imilarly maintained throughout life by proliferative self-renewal
ut are ﬁrst established shortly after birth by a fetal monocyte pop-
lation [90]. Dermal and intestinal macrophages are exceptions as
hey are of bone marrow origins [91–93].
We recently made the unexpected discovery that IL-4 can induce
acrophages to proliferate well beyond levels required for steady
tate renewal. We  were investigating the contribution of blood
onocytes to helminth killing in a model of ﬁlarial nematode infec-
ion in which the adult parasites reside in the pleural space. To
ur surprise, monocyte depletion had no impact on the very large
ncrease in macrophage numbers at the site of infection [94]. We
ere able to establish that in this model IL-4 induces a novel form
f ‘inﬂammation’ in which the increase in cell number is due to
roliferation rather than blood cell recruitment. We  observed sim-
lar proliferative expansion in the peritoneal cavity of mice infected
ith the GI nematode, H. polygyrus [62]. We  were also able to estab-
ish that when macrophages were recruited from the blood, IL-4
as still capable of inducing further proliferation and alternative
ctivation as measured by RELM,  Ym1  and arginase production
94]. It now becomes necessary to establish in each model the rela-
ive contribution of resident vs. recruited macrophage populations.
wo recent studies in models of schistosomiasis have demonstrated
hat despite proliferation of resident macrophages during infection,
he dominant route for increased macrophage numbers is blood
onocyte recruitment not local proliferation [95,96].
Both recruited and resident macrophages can become alterna-
ively activated by IL-4 [94]. This raises critical questions about the
ifferential function of resident vs. recruited macrophages. Beyond
heir location, the longevity of many tissue resident macrophages
ould support a role for maintenance of tissue integrity. Micro-
rray analysis that compared IL-4-activated macrophages from
esident or monocyte-derived origin illustrated that their func-
ions are likely to be highly distinct, with tissue-resident cells
aking on a prominent role in maintenance of homeostasis, rather
hen immune regulation [97]. Although tissue resident cells are
ikely to have major roles in tissue protection, these functions
ight be taken over by recruited cells that get activated by type 2
ytokines. We  ﬁnd that IL-4 strongly induces a non-inﬂammatory
henotype, with the down regulation of chemokine receptors that
ay  be involved in the trafﬁcking of macrophages beyond the
nfection or injury site [22]. IL-4R signaling also actively shuts
own pro-inﬂammatory chemokine production and promotes an
icosanoid environment dominated by anti-inﬂammatory lipid
ediators [22]. The ability of IL-4 to drive macrophage prolifer-
tion is evidence of the fundamental non-inﬂammatory nature of
he macrophage response in the context of type 2 immunity. Local
roliferation allows expansion of a large effector cell pool, avoiding
he need for recruitment of potentially damaging neutrophils and
onocytes. However, a proliferative response is necessarily much
lower than recruitment from the blood and may  be the dominant
echanism only when the risk of microbial insult is sufﬁciently low
Box 1).
. Eosinophils
Through release of toxic granular proteins, eosinophils have
lassically been viewed as key effector cells in host-defense against
elminth parasites but also in pathologies of allergic diseases.
hile circumstantial data has long associated eosinophils with tis-
ue injury and repair, few studies have explored the relationship
irectly.tributes to tissue repair?
4.1. Eosinophils as anti-parasite effector cells
Eosinophils accumulate following nematode infection, largely
in response to IL-5, a cytokine not only critical for recruitment
but also eosinophil differentiation from the bone marrow [98].
Early studies of IL-5, and by association eosinophils, contributed
to the notion that eosinophils form an integral part of the anti-
parasite effector mechanism. However, as the years went on,
it became clear that while eosinophils could mediate parasite
killing, these observations were parasite, stage and tissue spe-
ciﬁc. In vitro data still provides some of the most compelling
evidence that eosinophils participate in helminth destruction
and such approaches provided a direct means of showing that
eosinophils can attach to the cuticular surface of larvae [99],
release damaging mediators [100] and kill worms in antibody and
complement dependent fashion [99,101,102]. However, demon-
strating a role of eosinophil-mediated parasite killing in vivo has
been fraught with contradictions in the literature. Discrepancies
typically reﬂect the varying methods of depleting eosinophils or
triggering eosinophilia, the type of parasite and stage studied.
In the case of N. brasiliensis infection, data demonstrating a role
for eosinophil-mediated killing in vivo was  relatively straightfor-
ward. Mice with high eosinophilia driven by IL-5-overexpression
exhibited lower worm burdens following primary infection [103],
with eosinophils and/or IL-5 likely mediating their action on
migrating larval stages in the skin and lung [104,105]. Similarly
several groups have demonstrated the importance of IL-5 and/or
eosinophils in protection against larval stages of ﬁlarial nematodes
[106–108]. An intriguing observation is that ﬁlarial larvae accel-
erate their development and reproduce earlier in the face of an
eosinophil threat [109]. In contrast to these studies, ablation of
IL-5 either through genetic manipulation or antibody treatment
has shown little effect on parasite burdens in Schistosoma mansoni
[110], Trichinella spiralis [111] or Trichuris muris [112] infection. In
some cases reduced eosinophil numbers even enhanced infectiv-
ity of Strongylida species [113,114] consistent with the regulatory
properties associated with eosinophils [98].
In addition to IL-5 manipulation, mice genetically deﬁcient
in eosinophil chemotactic receptor CCR3 or factor eotaxin-1, or
even eosinophil deﬁcient mice (dblGATA or PHIL) have provided
additional direct evidence for the importance of eosinophils in gen-
erating protective immunity against ﬁlarial nematodes [115–117].
Furthermore, eosinophil peroxidase (EPO) and major basic protein
(MBP) are important in controlling infection to some parasites [118]
but not others [116] showing a direct role for proteins produced by
eosinophils following degranulation.
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Aside from the ability to release cytotoxic mediators in the
resence of an invading parasite, eosinophils can also regulate
mportant immune mechanisms, thereby adding to host-protective
ffects against helminths. Eosinophils are a rapid source of IL-
 and IL-13 cytokines during helminth infection. Combined with
he ability to process and present antigens [119] it would be
asy to speculate that eosinophils contribute to host-parasite
mmunity through initiation of type 2 responses. Indeed mice deﬁ-
ient in eosinophils generally exhibit reduced type 2 responses
120–123]. However, in a recent study by Voehringer et al.
124] eosinophil-derived IL-4 was redundant for primary protec-
ion against N. brasiliensis infection. The speciﬁc contribution of
osinophil-derived IL-4 to type 2 immunity still needs to be diss-
cted and may  be complicated by differences in mouse genetic
ackgrounds and model systems used.
Overall these observations leave no doubt that in many settings
osinophils can mediate protective immunity against helminth
nfection and promote type 2 immunity. However, in light of var-
ed observations using different approaches to deplete eosinophils
r eosinophil proteins in vivo, questions still remain as to whether
ther mechanisms of host-protection play a more dominant role.
n the case of T. spiralis infection, parasite killing occurred at a
reater rate in the absence of eosinophils following a switch in
he immune response toward enhanced iNOS production [125,126].
uch studies highlight the importance of having a detailed under-
tanding of immune responses during infection and not just the
bsence/presence of one cell type.
.2. Eosinophils during injury and repair
Like type 2 responses and macrophages, eosinophils have also
een implicated during repair of damage tissue. However, most
nformation regarding the role of eosinophils in tissue repair has
een inferred from studying eosinophils during pathogenic tis-
ue remodeling associated with ﬁbrosis and asthma. Considering
osinophils were reported in 1977 to localize to sterile tissue sites
127], it is surprising that there have been so few studies showing a
irect role for eosinophils in tissue repair. In fact, some of the most
ompelling evidence has come only in the last 2 years in two stud-
es which describe a clear mechanism through which eosinophils
an promote regeneration of damaged tissue [128,129]. The liver
as an extraordinary ability to regenerate after injury and partial
epatectomy, through well-orchestrated timely events that lead
p to proliferation of heptocytes. Little is known about the immune
esponses that lead up to the proliferative burst of hepatocytes. In a
tudy by Goh et al. [128], mice deﬁcient in eosinophils (dblGATA)
xhibited a 50% reduction in hepatocyte proliferation following
Cl4-induced liver damage. In this model, eosinophil-derived IL-4
as critical in generating IL-4R-dependent proliferation of hepa-
ocytes, directly linking eosinophil-initiated type 2 responses to
iver regeneration. Similar responses could be attributed to mus-
le regeneration, whereby rapid eosinophil recruitment follows
njury and IL-4 secreted by eosinophils activates muscle resident
bro/adipocyte progenitors [129]. Together these studies illustrate
ritical roles for eosinophils and type 2 cytokines in tissue regen-
ration.
Helminth infection and host damage go hand in hand, and one
f the ﬁrst responders to the ensuing type 2 response is eosinophils.
t would be reasonable to postulate from studies in tissue regen-
ration, that eosinophils during helminth infection have a role
o play in host repair. Eosinophils are a rapid source of type 2
ytokines during helminth infection, and while eosinophil-derived
L-4 may  not be essential for parasite killing [124], it may  well be
nvolved in repair following helminth migration. Consistent with
his hypothesis, failure to repair the lungs of IL-9R-deﬁcient mice
ollowing migration of N. brasiliensis larvae, was accompanied by aImmunology 26 (2014) 329–340 335
signiﬁcant reduction in eosinophils [52]. While the failure to repair
in this study could be attributed to reduced AAM and ILC2s,
eosinophil derived-IL-4/13 or other eosinophil derived factors may
also be critical players.
Aside from type 2 cytokines, many other wound healing regula-
tors, such as RELM,  TGF and TGF, ﬁbroblast growth factors and
collagen regulating enzymes are highly secreted by eosinophils.
For example, at 7 days post-wounding, eosinophils peak in num-
ber and produce TGF [130,131], which is known to facilitate
repair of cutaneous wounds [132]. Key to the proposed mecha-
nisms by which eosinophils may  regulate wound healing, is studies
that describe an interaction between eosinophils and ﬁbroblasts
promoting proliferation and matrix production [133]. Eosinophil
derived products such as eosinophil cationic protein may also be
key players in regulation of the extracellular matrix [134]. Interest-
ingly, alarmin IL-33 together with IL-31 was  recently suggested to
activate the eosinophil–ﬁbroblast interaction [135]. These observa-
tions together with the fact that IL-33 activates eosinophils [136]
and is a key cytokine in altering the immune systems to injury
as discussed above, strongly implicates eosinophils as signiﬁcant
players in wound repair.
Despite overwhelming circumstantial evidence that eosinophils
will contribute to repair, genetic approaches to explore the role of
IL-5/eosinophils in parasite killing have generally failed to see an
impact of eosinophils in wound repair. In fact the converse has been
shown, with IL-5-transgenic mice displaying a delay in incisional
wound repair [137]. The repair-related properties of eosinophils are
so diverse and likely implicate remodeling of extracellular matrix,
which involves both breakdown and synthesis. Thus, their con-
tribution to repair may  be time point and context dependent –
potentially promoting or slowing the repair process. It is striking
that in both wound repair and parasite killing models, the data
has often been contradictory. It is almost certain that this dispar-
ity is due to the multi-functionality of eosinophils and that for
each model, the contribution of eosinophils will need to be diss-
ected at each time point and with a good understanding of cellular
cross-talk. What is abundantly clear is that there is an enormous
opportunity in the area of eosinophil biology to gain new insight
into repair and regeneration processes, especially in the context of
type 2 immunity.
5. The effector molecules: two examples
5.1. Arginase
Arginase 1 provides an ideal example of a molecule with mul-
tiple functions in the context of type 2 immunity. One of the
ﬁrst proteins described in association with alternative macrophage
activation [138], arginase 1 remains a paradigm for the cross-
regulatory nature of classical vs. alternative activation. Because
arginase competes with iNOS for their mutual substrate arginine,
arginase suppresses the NO mediated anti-microbial pathways of
classically activated macrophages. Thus suppression of inﬂamma-
tory pathways is one of the key functions of arginase 1. Importantly,
this occurs not only through inhibition of iNOS but by direct effects
on T cell function. T cells are exquisitely sensitive to arginine con-
centration and depletion of arginine through arginase activation
results in impaired T cell function [139–141].
Another well established property of arginase 1 is that of tis-
sue remodeling and repair. This is because ornithine generated by
arginase activity can be converted to polyamines and proline, sup-
porting cell proliferation and collagen synthesis respectively [142].
These properties also explain the frequent association of arginase
with ﬁbrosis and in particular asthma, where it is believed to con-
tribute to pathological tissue remodeling [68]. More unexpected,
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as been the ﬁnding that arginase acts as effector molecule against
ematode infection. In models of secondary infection, Anthony
t al. [2] demonstrated that arginase inhibition prevented worm
xpulsion of H. polygyrus,  while Obato-Ninomiya et al. revealed
 critical role for macrophage-derived arginase in trapping N.
rasiliensis larvae in the skin [143]. The mechanism by which
rginase enhances worm expulsion or killing is to yet established
ut direct effects on the worm are supported by work showing that
he arginase 1 product L-ornithine inhibited the motility of H. poly-
yrus larvae [55]. Thus, the arginase metabolite L-ornithine which
s a critical substrate for the wound healing machinery [96] also has
nti-nematode effector function.
Arginase is one of the few examples of type 2 effectors
here we have some handle on the basis for differential func-
ion. Using macrophage speciﬁc arginase deﬁcient mice, the Wynn
roup demonstrated that the T cell suppressive but not the pro-
epair/ﬁbrosis functions were mediated by macrophages [144].
hey postulate that ﬁbroblasts are the critical arginase source for
he promotion of collagen deposition. Further, the protective func-
ions of arginase producing macrophages may  be tissue-speciﬁc
s mice lacking arginase producing macrophages had exagger-
ted inﬂammatory responses in a model of liver ﬁbrosis [144] but
naltered inﬂammatory responses in several lung models [145].
mportantly, although arginase is induced by IL-4 and IL-13 and
hus associated with type 2 immunity it can also be induced by
icrobial stimuli [146] and likely serves anti-inﬂammatory and
epair functions in these contexts as well.
.2. Amphiregulin
Another example of a single molecule performing wound repair,
nﬂammatory suppression and anti-nematode effector function is
he EGF-like growth factor, Amphiregulin (AREG). AREG is an EGF-
eceptor ligand expressed by a range of immune cells associated
ith type 2 immunity, including Th2 cells, mast cells and ILC2s
52,147,148]. The high level identity between mouse and human
REG and the wide clinical use of EGF-R antagonists make AREG an
ttractive research subject.
In 2006, Zaiss and colleagues [147] demonstrated using gene-
eﬁcient mice that AREG was needed for efﬁcient expulsion of the
astrointestinal nematode, Trichuris muris. The failure to expel the
arasite in AREG−/− mice was associated with a reduced prolifer-
tion of gut epithelial cells, a process known to be important for
esistance to T. muris [149]. Subsequently several groups demon-
trated an important role for AREG in tissue repair and homeostasis.
n these studies AREG from ILCs promoted lung epithelial cell
ntegrity and airway remodeling following ﬂu infection [150]. T
egulatory cell derived AREG was needed for skeletal muscle repair
151] and administration of AREG signiﬁcantly reduced the mor-
ality of mice co-infected with inﬂuenza and Listeria by protecting
gainst lung damage [152]. The tissue protective role of AREG in
he context of type 2 immunity has been supported by recent work
llustrating the central role of AREG producing ILC2s in repair of
ematode induced lung damage [52]. Not surprisingly, given it’s
ontribution to wound healing, AREG is also associated with the
etrimental consequences of repair, ﬁbrosis [153]. Finally, recent
ata also demonstrates that mast cell derived AREG is needed for
ptimal T regulatory cell function [148] and thus AREG likely con-
ributes to the to the full type 2 triad of nematode control, wound
epair and local suppression of inﬂammation.. Adaptive immune repair
Helminth infection models can bring clarity to our under-
tanding of wound repair by providing an explanation for theImmunology 26 (2014) 329–340
contribution of adaptive Th2 cells to wound repair pathways. The
cardinal features of adaptive immunity are antigen speciﬁcity and
memory and it is in the context of continual and repeated expo-
sure to tissue damaging parasites that we  might need to remember
to repair our wounds in an antigen speciﬁc manner [12]. Thus Th2
cells would function to both accelerate repair and worm expulsion
or killing. Although Th2 cells are an obvious source of IL-4 or IL-
13 that mediates worm killing or tissue repair, other innate cells
make important contributions [124] and in particular ILC2s seem
to be essential in some settings [52]. However, a reliance solely
on innate sources cannot explain data in which there is a failure
of lungs to repair efﬁciently in N. brasiliensis-infected SCID mice
and alternative activation cannot be sustained beyond the early
innate response [154]. In a model of ﬁlarial nematode infection
using mice lacking either RAG genes or class II, there is a striking
lack of macrophages, and the few that are there do not alterna-
tively activate [69]. Similarly, macrophages fail to proliferate in L.
sigmodontis infected RAG deﬁcient mice and alternative activation
and IL-4 dependent proliferation occur only after the onset of the
adaptive immune response [62,94]. Additionally, macrophage pro-
liferation requires higher doses of IL-4 than induction of RELM,
Ym1 or arginase [62] suggesting that proliferation may  be partic-
ular dependent on close cellular interactions. Together the data
suggest macrophage proliferation and in some contexts alternative
activation requires cognate interaction that would be provided by
the T cell receptor. Nonetheless, IL-4R activation of macrophages
does occur in settings without adaptive immune response [69,154],
and in many contexts innate cells will sufﬁce. It may  be that T cells
are needed for speciﬁc functions, such as macrophage proliferation
and IgE production [124]. The challenge will be to deﬁne the balance
of T-helper vs innate cells in different circumstances, and critically
to determine whether there is an important adaptive component
to tissue repair in the absence of helminth infection.
6.1. Antibodies
Antibodies are the quintessential adaptive immune effector
molecules, and are a central feature of Th2 immunity. A role for
antibody in immune protection against helminth re-infection has
long been established but the need for antibody in primary infec-
tion is less consistent and likely parasite and tissue dependent. The
contribution of antibody to anti-helminth immunity was reviewed
recently [155]. With the close link between parasite control and
tissue repair, the expectation would be that antibody would also
be involved in promoting repair. Recent data from the Harris lab,
demonstrates that this is indeed the case [55]. Using mice that
lack antibodies (JH−/−) or activating Fc receptors (FcR−/−), they
demonstrate in a model of secondary H. polygyrus infection that
antibodies activate macrophages to trap and immobilize infective
larvae and thus prevent parasite-induced damage. Macrophage
activation via antibody led to the induction of tissue repair genes
and more limited tissue damage. Of note, the ability of antibodies
to induce arginase in this system was  independent of the IL-4R,
but in its absence macrophages fail to accumulate at the infection
site. Thus, Th2 cytokines may  be necessary for generating sufﬁcient
macrophage numbers, as well as an appropriate antibody response
but induction of the key effector molecules such as arginase may
occur through alternative routes.
The study described above was the ﬁrst to demonstrate the dual
contribution of antibody to parasite control and tissue repair. IgE, in
particular, is the direct result of B-cell class switching in response
to Th2 cytokines [155]. IgE is almost universally associated with
helminth infection and is strongly indicative of adaptive type 2
immune activation in the host. Two recent studies on IgE, that
do not involve helminths, provide new insight into the role that
antibody may  play in tissue protection [156,157]. IgE is, of course,
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est known as the key mediator of pathological allergic reactions
n atopic individuals. In these two studies, mice exposed to bee
enom mounted Th2 responses and the IgE response was  protec-
ive against challenge. Palm et al. demonstrated the involvement
f IL-33 as a sensor of the tissue damage caused by the bee venom
156]. Thus, a major function of IgE and antibodies may  be to pro-
ect against future damage associated with a particular insult such
s venom or toxins. The strong association of IgE with helminth
nfection may  be because these pathways ﬁrst evolved to neutral-
ze proteins that cause damage, such as the parasite proteases used
o migrate through the tissue. IgE, however, can also directly tar-
et the parasite. Thus, antibody responses, like many other aspects
f type 2 immunity such as collagen deposition, mucus production
nd epithelial cell turnover, may  have been mechanisms of pro-
ection against tissue injury, that evolved into anti-worm effector
esponses to further promote host ﬁtness.
. Conclusions
As this review illustrates, Th2 associated molecules have mul-
iple functions, with many actively contributing to both repair and
arasite control. How does a single molecule perform these distinct
unctions? In some cases, it may  be that the actual physiological
echanism is the same. For example, amphiregulin’s pro-repair
nd pro-nematode expulsion properties may  reﬂect a common
ffect on epithelial cell proliferation [147]. However, it is unlikely
o be that straightforward. For example, arginase activity results
n a several downstream effectors that may  each have different
roperties and Wynn and colleagues have elegantly illustrated that
rginase source is a critical determinant of function [144]. Other
actors including necessary co-factors, timing, receptor availabil-
ty and whether the effector molecule is soluble or membrane
ound will determine the ultimate outcome of a particular effec-
or molecule in each setting. Whether there are common rules that
pply to many type 2 molecules involved in both repair and parasite
ontrol has yet to be determined.
This review has focussed on the overlapping functions of type 2
mmunity in tissue repair and control of helminth parasites. How-
ver, it is now recognized that type 2 immunity and in particular
AM contribute to a wide range of process that include metabolic
egulation, adaptive thermogenesis and tumor progression [158].
or just one example, the ability of IL-33 to promote the alternative
ctivation of macrophages, results in outcomes that go well beyond
hat of wound repair or parasite control and include a protective
ffect on atherosclerosis [159]. It is likely, that these other functions
re all tied to evolutionary adaptations of IL-4 as a tissue protec-
ive pathway. By deciphering the ancient evolutionary relationship
etween immunity to parasites and adaptive immune repair, we
ay  learn valuable lessons for both the protection against helminth
nfection and pathways to promote healthy tissues.
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